CMB International Capital Corporation Ltd, a wholly-owned subsidiary of China Merchants Bank, recently led a $65 million...
Morphotek Inc., a subsidiary of Eisai Inc., has licensed its eribulin-linker payload to Bliss Biopharmaceutical Co., Ltd...
China-based BeiGene, , a commercial-stage biopharmaceutical company focused on developing and commercializing inno...
Ubiquigent Limited has entered into a multi-year strategic R&D collaboration agreement with FORMA Therapeutics for t...
CICC Capital Management Company Limited, a wholly-owned subsidiary of China International Capital Corporation Limited (C...
Eli Lilly has offloaded three small molecule therapeutic candidates for the potential treatment of non-alcoholic steatoh...
Equashield a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, announced that it will be l...
China based CMAB Biopharma Inc. (CMAB), a full-service contract development and manufacturing organization (CDMO) provid...
Nabriva Therapeutics, a clinical stage biopharmaceutical company engaged in the research and development of novel anti-i...
Fresenius Medical Care, the world's largest provider of dialysis products and services, has announced a new partnership ...
Hua Medicine, a clinical-stage drug development company developing novel therapies for the treatment of Type 2 diabetes,...
Singlera Genomics, a non-invasive genetic diagnostics company that focuses on early-stage cancer detection, has succ...
Boehringer Ingelheim (BI) has teamed up with two China animal health companies, Beijing KangMu Omni-Hones...
Allergan plc announces the launch of Ozurdex® (dexamethasone intravitreal implant 0.7 mg) in China for the treatment...
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...
Inovio Pharmaceuticals, today announced that it has inked an agreement providing ApolloBio with the exclusive right to d...
Akonni Biosystems Inc. and Chinese in vitro diagnostics company, Righton, recently announced a commercial agreement that...
Dova Pharmaceuticals, Inc. has entered into an agreement through its wholly owned subsidiary, AkaRx, Inc., granting Shan...
